Endophthalmitis in patients with retained lens fragments after phacoemulsification

J. E. Kim, Harry W Flynn, P. E. Rubsamen, T. G. Murray, Janet L Davis, William E Smiddy

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Purpose: To review the treatment and outcomes of patients presenting with concurrent endophthalmitis and retained lens fragments after phacoemulsification. Methods: A retrospective chart review was conducted on patients presenting with culture-proven endophthalmitis and retained lens fragments after phacoemulsification between 1990 and 1994. Results: Five patients were identified with culture-proven endophthalmitis and retained lens fragments after phacoemulsification. In all patients, coagulase-negative staphylococci were cultured from the vitreous fluid. One patient also had positive cultures for Proteus mirabilis and Escherichia coli. The interval between cataract surgery and treatment ranged from 5 days to 6 months. Echography was beneficial in showing retained lens fragments in five of five patients when media opacities obscured the view of the fundus. Four patients had vitrectomy and removal of retained lens fragments during their initial treatment. The fifth patient was treated with intravitreal antibiotics alone and continued to have marked inflammation, eventually requiring vitrectomy for removal of the retained lens fragments. A final visual acuity of 20/400 or better was achieved in four of the five patients. Conclusions: Patients may present with endophthalmitis in the setting of retained lens fragments after phacoemulsification. In such cases, the preferred initial management may be pars plana vitrectomy, removal of retained lens fragments, and injection of intraocular antibiotics. In eyes with endophthalmitis and opaque media, echography is a useful screening modality.

Original languageEnglish
Pages (from-to)575-578
Number of pages4
JournalOphthalmology
Volume103
Issue number4
StatePublished - Apr 25 1996

Fingerprint

Endophthalmitis
Phacoemulsification
Lenses
Vitrectomy
Ultrasonography
Intraocular Injections
Anti-Bacterial Agents
Proteus mirabilis
Temazepam
Coagulase
Staphylococcus
Cataract
Visual Acuity
Escherichia coli
Inflammation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Endophthalmitis in patients with retained lens fragments after phacoemulsification. / Kim, J. E.; Flynn, Harry W; Rubsamen, P. E.; Murray, T. G.; Davis, Janet L; Smiddy, William E.

In: Ophthalmology, Vol. 103, No. 4, 25.04.1996, p. 575-578.

Research output: Contribution to journalArticle

@article{b68df0bc83a344ef88d61bdf6dcdc15b,
title = "Endophthalmitis in patients with retained lens fragments after phacoemulsification",
abstract = "Purpose: To review the treatment and outcomes of patients presenting with concurrent endophthalmitis and retained lens fragments after phacoemulsification. Methods: A retrospective chart review was conducted on patients presenting with culture-proven endophthalmitis and retained lens fragments after phacoemulsification between 1990 and 1994. Results: Five patients were identified with culture-proven endophthalmitis and retained lens fragments after phacoemulsification. In all patients, coagulase-negative staphylococci were cultured from the vitreous fluid. One patient also had positive cultures for Proteus mirabilis and Escherichia coli. The interval between cataract surgery and treatment ranged from 5 days to 6 months. Echography was beneficial in showing retained lens fragments in five of five patients when media opacities obscured the view of the fundus. Four patients had vitrectomy and removal of retained lens fragments during their initial treatment. The fifth patient was treated with intravitreal antibiotics alone and continued to have marked inflammation, eventually requiring vitrectomy for removal of the retained lens fragments. A final visual acuity of 20/400 or better was achieved in four of the five patients. Conclusions: Patients may present with endophthalmitis in the setting of retained lens fragments after phacoemulsification. In such cases, the preferred initial management may be pars plana vitrectomy, removal of retained lens fragments, and injection of intraocular antibiotics. In eyes with endophthalmitis and opaque media, echography is a useful screening modality.",
author = "Kim, {J. E.} and Flynn, {Harry W} and Rubsamen, {P. E.} and Murray, {T. G.} and Davis, {Janet L} and Smiddy, {William E}",
year = "1996",
month = "4",
day = "25",
language = "English",
volume = "103",
pages = "575--578",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Endophthalmitis in patients with retained lens fragments after phacoemulsification

AU - Kim, J. E.

AU - Flynn, Harry W

AU - Rubsamen, P. E.

AU - Murray, T. G.

AU - Davis, Janet L

AU - Smiddy, William E

PY - 1996/4/25

Y1 - 1996/4/25

N2 - Purpose: To review the treatment and outcomes of patients presenting with concurrent endophthalmitis and retained lens fragments after phacoemulsification. Methods: A retrospective chart review was conducted on patients presenting with culture-proven endophthalmitis and retained lens fragments after phacoemulsification between 1990 and 1994. Results: Five patients were identified with culture-proven endophthalmitis and retained lens fragments after phacoemulsification. In all patients, coagulase-negative staphylococci were cultured from the vitreous fluid. One patient also had positive cultures for Proteus mirabilis and Escherichia coli. The interval between cataract surgery and treatment ranged from 5 days to 6 months. Echography was beneficial in showing retained lens fragments in five of five patients when media opacities obscured the view of the fundus. Four patients had vitrectomy and removal of retained lens fragments during their initial treatment. The fifth patient was treated with intravitreal antibiotics alone and continued to have marked inflammation, eventually requiring vitrectomy for removal of the retained lens fragments. A final visual acuity of 20/400 or better was achieved in four of the five patients. Conclusions: Patients may present with endophthalmitis in the setting of retained lens fragments after phacoemulsification. In such cases, the preferred initial management may be pars plana vitrectomy, removal of retained lens fragments, and injection of intraocular antibiotics. In eyes with endophthalmitis and opaque media, echography is a useful screening modality.

AB - Purpose: To review the treatment and outcomes of patients presenting with concurrent endophthalmitis and retained lens fragments after phacoemulsification. Methods: A retrospective chart review was conducted on patients presenting with culture-proven endophthalmitis and retained lens fragments after phacoemulsification between 1990 and 1994. Results: Five patients were identified with culture-proven endophthalmitis and retained lens fragments after phacoemulsification. In all patients, coagulase-negative staphylococci were cultured from the vitreous fluid. One patient also had positive cultures for Proteus mirabilis and Escherichia coli. The interval between cataract surgery and treatment ranged from 5 days to 6 months. Echography was beneficial in showing retained lens fragments in five of five patients when media opacities obscured the view of the fundus. Four patients had vitrectomy and removal of retained lens fragments during their initial treatment. The fifth patient was treated with intravitreal antibiotics alone and continued to have marked inflammation, eventually requiring vitrectomy for removal of the retained lens fragments. A final visual acuity of 20/400 or better was achieved in four of the five patients. Conclusions: Patients may present with endophthalmitis in the setting of retained lens fragments after phacoemulsification. In such cases, the preferred initial management may be pars plana vitrectomy, removal of retained lens fragments, and injection of intraocular antibiotics. In eyes with endophthalmitis and opaque media, echography is a useful screening modality.

UR - http://www.scopus.com/inward/record.url?scp=0029920963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029920963&partnerID=8YFLogxK

M3 - Article

C2 - 8618754

AN - SCOPUS:0029920963

VL - 103

SP - 575

EP - 578

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 4

ER -